The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA

BACKGROUND: Multi-cancer early detection (MCED) testing could increase detection of cancer at early stages, when survival outcomes are better and treatment costs are lower, but is expected to increase screening costs. This study modeled an MCED test for 19 solid cancers in a US population and estima...

Descripción completa

Detalles Bibliográficos
Autores principales: Tafazzoli, Ali, Ramsey, Scott D., Shaul, Alissa, Chavan, Ameya, Ye, Weicheng, Kansal, Anuraag R., Ofman, Josh, Fendrick, A. Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550746/
https://www.ncbi.nlm.nih.gov/pubmed/36038710
http://dx.doi.org/10.1007/s40273-022-01181-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550746/
https://www.ncbi.nlm.nih.gov/pubmed/36038710
http://dx.doi.org/10.1007/s40273-022-01181-3

Ejemplares similares